Staphylococcus aureus adaptation to vancomycin influences phage susceptibility

Jack Å H Abrahamsson1, Esther Lehmann1, Anaëlle Fait2

  • 1Department of Veterinary and Animal Sciences, Section for Bacteria and Viruses, University of Copenhagen, Frederiksberg, 1870, Copenhagen, Denmark.

Research in Microbiology
|September 28, 2025
PubMed

Insights

Bacterial phages show altered efficacy against Staphylococcus aureus strains with vancomycin-intermediate susceptibility (VISA). VISA development can change phage susceptibility, impacting phage therapy effectiveness and necessitating careful consideration of antibiotic-drug interactions.

Area of Science:

  • Microbiology
  • Bacteriology
  • Virology

Background:

  • Bacterial phages are promising therapeutics against antibiotic-resistant pathogens.
  • Staphylococcus aureus strains, particularly methicillin-resistant (MRSA) and vancomycin-intermediate susceptible (VISA) strains, commonly exhibit resistance to antibiotics.
  • Wall teichoic acid (WTA) glycopolymers on the bacterial cell wall serve as primary phage receptors.

Purpose of the Study:

  • To investigate how mutations leading to vancomycin-intermediate susceptibility affect phage susceptibility in Staphylococcus aureus.
  • To evaluate the impact of antibiotic-driven physiological changes on phage therapy efficacy.
  • To explore the relationship between WTA glycosylation and phage resistance.

Main Methods:

  • Analysis of phage susceptibility in clinical and laboratory-evolved VISA strains of Staphylococcus aureus.
  • Infection modeling using therapeutically relevant myoviruses (ΦIPLA-RODI, Stab20, Stab21, ΦK).
  • Assessment of WTA glycosylation patterns and phage therapy efficacy in a Galleria mellonella infection model.

Main Results:

  • VISA development in Staphylococcus aureus led to variable changes in phage susceptibility, with some strains becoming more resistant and others more susceptible.
  • Laboratory-evolved VISA strains showed resistance to certain phages, while some became susceptible to previously resistant phages.
  • Altered WTA glycosylation correlated with changes in phage susceptibility, and resistance compromised phage therapy effectiveness in vivo.

Conclusions:

  • Antibiotic-induced alterations in bacterial physiology, specifically WTA glycosylation, significantly impact phage susceptibility in Staphylococcus aureus.
  • Understanding these changes is crucial for developing effective phage-based therapies, especially when used in combination with antibiotics.
  • Future phage therapy strategies must account for antibiotic-driven bacterial adaptations to ensure successful treatment outcomes.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.4K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.4K